1 / 4

Osteoarthritis Therapeutics Market Size, Status and Forecast, 2026

Osteoarthritis Therapeutics Latest Research Report. Complete Market Research, Market Analysis, CAGR, Trends, Major Players, Market Share, Market Size.

KeenCatPost
Télécharger la présentation

Osteoarthritis Therapeutics Market Size, Status and Forecast, 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Welcome To DataIntelo Osteoarthritis Therapeutics Market Size, Status and Forecast, 2026 The global osteoarthritis therapeutics market size is anticipated to expand at a substantial CAGR during the forecast period, 2020–2026, owing to the rapid increase in the elderly and overweight population and the surge in the occurrence of osteoarthritis illness. Market Trends, Drivers, Restraints, and Opportunities: •Rapid growth in geriatric and obese populations and increase in prevalence of osteoarthritis are anticipated to drive the growth of the market. •Surge in occurrence of sports injuries is projected to propel market growth in the coming years. •Obtainability of substitute non-drug pain management therapies is anticipated to hamper market growth •Danger of adverse cardiac events related to the usage of nonsteroidal anti- inflammatory drugs (NSAIDs) for the treatment of osteoarthritis is expected to hinder market growth.

  2. •Partnerships focused on novel product launches and increasing prevalence of osteoarthritis in developing regions are projected to create growth opportunities in the market. •Several osteoarthritis studies are being conducted for the re-growth the cartilage using stem cells treated with molecules. Therefore, ongoing studies and increasing government aid for the generation of new therapeutics are projected to create market growth opportunities. Scope of the report: The report on osteoarthritis therapeutics market includes an assessment of the market, size, share, trends, segments and regional markets. Overview and dynamics have been included in the report. Attributes Details Base Year 2019 Historic Data 2015–2019 Forecast Period 2020–2026 North America, Europe, Asia Pacific, Latin America, Middle East & Africa Regional Scope Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities and revenue forecast Report Coverage Request for Free Sample: https://dataintelo.com/request- sample/?reportId=113156 Osteoarthritis Therapeutics Market Segment Insights: Huge patient pool for knee osteoarthritis is expected to drive the growth of the segment In terms of anatomy, the osteoarthritis therapeutics market has been divided into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis, and small-joint

  3. osteoarthritis. The knee osteoarthritis segment is projected to witness substantial growth during the forecast period. Expansion of the market is attributed to the enormous number of patients suffering from knee osteoarthritis. Escalating usage of ultrafiltration is projected to propel the growth of the segment during the forecast period Based on drug types, the market has been categorized as viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. The nonsteroidal anti-inflammatory drugs (NSAIDs) segment has been sub-segmented into aspirin, diclofenac, ibuprofen, naproxen, and other molecules. The analgesics segment has been classified as acetaminophen and duloxetine. The viscosupplementation agents segment is expected to grow at a substantial pace during the forecast period owing to the increasing prevalence and incidence of the knee osteoarthritis. Market in Europe is anticipated to expand at a considerable growth rate in the coming years On the basis of regions, the global osteoarthritis therapeutics market has been fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Europe is estimated to grow significantly in the coming years due to increasing occurrences of osteoarthritis, growing elderly population, and rising obesity rates in numerous European nations. Competitive Landscape: Major companies operating in the global osteoarthritis therapeutics market are Abbott, Anika Therapeutics, Bayer AG, Eli Lilly, Flexion Therapeutics, GlaxoSmithKline Plc, Horizon Therapeutics, Johnson & Johnson, Pfizer, and Sanofi. Major companies implement numerous strategic initiatives such as acquisitions, product launches, agreements, collaborations, technological upgrades, mergers, and partnerships to gain market share and sustain the competition in the market. Segments Covered in the Report The global osteoarthritis therapeutics market has been segmented based on anatomy, drug types, route of administration, and regions.

  4. By Anatomy •Knee Osteoarthritis •Hip Osteoarthritis •Hand Osteoarthritis •Small-joint Osteoarthritis By Drug Types •Viscosupplementation Agents •Nonsteroidal Anti-Inflammatory Drugs •Aspirin •Diclofenac •Ibuprofen •Naproxen •Other Molecules •Analgesics •Acetaminophen •Duloxetine •Corticosteroids By Route of Administration •Oral Route •Parenteral Route •Topical Route By Regions •North America •Europe •Asia Pacific •Latin America •Middle East & Africa Discover More @ https://dataintelo.com/

More Related